Health Catalyst Q4 revenue $69.2M (+7% YoY); Adjusted EBITDA loss narrows; board adds Matthew Kolb

Health Catalyst, Inc.

2022-FY EPS reported -$2.63 revenue$276,236,000

Q4 total revenue $69.2M (+7% YoY); full-year revenue $276.2M (+14% YoY).
GAAP net loss Q4 $35.8M vs $49.0M loss a year ago; full-year net loss $137.4M vs $153.2M.
Adjusted EBITDA Q4 -$0.6M (improved 90% from -$6.3M); full-year -$2.5M (improved 78% from -$11.2M).
Matthew Kolb (EVP/COO Carle Health) to join board effective July 1, 2023; Carle Health made open-market stock purchase.
CEO Dan Burton purchased shares on open market, estimates he is among top 20 shareholders.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Health Catalyst, Inc. reported Three Months Ended December 31, 2022 results: revenue $ 69,162, net income $ (35,782).

Period: Three Months Ended December 31, 2022
Revenue: $ 69,162
Net income: $ (35,782)
Result: reported results

Exact text from the filing

Financial Highlights for the Three and Twelve Months Ended December 31, 2022 Key Financial Metrics Three Months Ended December 31, Year over Year Change Twelve Months Ended December 31, Year over Year Change 2022 2021 2022 2021 GAAP Financial Data: (in thousands, except percentages) (in thousands, except percentages) Technology revenue $ 44,664 $ 40,088 11% $ 176,288 $ 147,718 19% Professional services revenue $ 24,498 $ 24,628 (1)% $ 99,948 $ 94,208 6% Total revenue $ 69,162 $ 64,716 7% $ 276,236 $ 241,926 14% Loss from operations $ (36,745) $ (44,765) 18% $ (140,005) $ (143,650) 3% Net loss $ (35,782) $ (48,992) 27% $ (137,403) $ (153,210) 10%

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Health Catalyst, Inc. reported Twelve Months Ended December 31, 2022 results: revenue $ 276,236, net income $ (137,403).

Period: Twelve Months Ended December 31, 2022
Revenue: $ 276,236
Net income: $ (137,403)
Result: reported results

Exact text from the filing

Financial Highlights for the Three and Twelve Months Ended December 31, 2022 Key Financial Metrics Three Months Ended December 31, Year over Year Change Twelve Months Ended December 31, Year over Year Change 2022 2021 2022 2021 GAAP Financial Data: (in thousands, except percentages) (in thousands, except percentages) Technology revenue $ 44,664 $ 40,088 11% $ 176,288 $ 147,718 19% Professional services revenue $ 24,498 $ 24,628 (1)% $ 99,948 $ 94,208 6% Total revenue $ 69,162 $ 64,716 7% $ 276,236 $ 241,926 14% Loss from operations $ (36,745) $ (44,765) 18% $ (140,005) $ (143,650) 3% Net loss $ (35,782) $ (48,992) 27% $ (137,403) $ (153,210) 10%

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Health Catalyst, Inc. filing history →

Source: SEC EDGAR

accession 0001636422-23-000026

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.